Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is Rp 1.967.710,86, with a 24-hour trading volume of Rp 14,29B. The asset's market cap is Rp 4,86P, after moving -0.45% in the last day.
Tokenized Merck & Co Inc is trading at Rp 1.978.036,61, with a tokenized market cap of Rp 14,7B and a 24-hour trading volume of Rp 15,46B. The tokenized asset has moved -0.03% in the past 24 hours.